 | • レポートコード：QYR9ST04221 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、好中球減少症治療の世界市場について調査・分析し、好中球減少症治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（顆粒球-コロニー刺激因子（G-CSF）、抗生物質、抗真菌薬）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の好中球減少症治療市場動向 ・主要企業別マーケットシェア ・好中球減少症治療の種類別市場規模2014-2019 （顆粒球-コロニー刺激因子（G-CSF）、抗生物質、抗真菌薬） ・好中球減少症治療の用途別市場規模2014-2019 （病院薬局、小売薬局、オンライン薬局） ・好中球減少症治療の北米市場：主要企業・種類別/用途別市場規模 ・好中球減少症治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・好中球減少症治療の中国市場：主要企業・種類別/用途別市場規模 ・好中球減少症治療の日本国内市場：主要企業・種類別/用途別市場規模 ・好中球減少症治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・好中球減少症治療のインド市場：主要企業・種類別/用途別市場規模 ・好中球減少症治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Amgen、Novartis、Teva Pharmaceutical、Hospira、Pfizer） ・好中球減少症治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Neutropenia is an abnormal condition, characterized by critically low levels of circulating neutrophils, a type of WBC found in the blood. These cells make up for the majority of circulating lymphocytes and help defend the body against infections by bacteria, viruses, and other pathogenic organisms. Decrease in the neutrophil count in blood makes a patient susceptible to infections and may even prove fatal. Therefore, the condition requires immediate prophylaxis.Novel therapies combined with growing cases of chemotherapy-induced neutropenia is one of the primary drivers for market growth. Moreover, the novel drug delivery technique also improves patient convenience leading to better patient adherence thus driving the market growth. Furthermore, since cancer is the known cause for developing neutropenia, the increasing cases of chemotherapy for the treatment of cancer will be a growth driver for the neutropenia treatment market.
In 2018, the global Neutropenia Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Neutropenia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Neutropenia Treatment development in United States, Europe and China.
The key players covered in this study
Amgen
Novartis
Teva Pharmaceutical
Hospira
Pfizer
…
Market segment by Type, the product can be split into
Granulocyte -colony- stimulating factor (G-CSF)
Antibiotics
Antifungal drugs
Market segment by Application, split into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Neutropenia Treatment status, future forecast, growth opportunity, key market and key players.
To present the Neutropenia Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Neutropenia Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Neutropenia Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Granulocyte -colony- stimulating factor (G-CSF)
1.4.3 Antibiotics
1.4.4 Antifungal drugs
1.5 Market by Application
1.5.1 Global Neutropenia Treatment Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Neutropenia Treatment Market Size
2.2 Neutropenia Treatment Growth Trends by Regions
2.2.1 Neutropenia Treatment Market Size by Regions (2014-2025)
2.2.2 Neutropenia Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Neutropenia Treatment Market Size by Manufacturers
3.1.1 Global Neutropenia Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Neutropenia Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Neutropenia Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Neutropenia Treatment Key Players Head office and Area Served
3.3 Key Players Neutropenia Treatment Product/Solution/Service
3.4 Date of Enter into Neutropenia Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Neutropenia Treatment Market Size by Type (2014-2019)
4.2 Global Neutropenia Treatment Market Size by Application (2014-2019)
5 United States
5.1 United States Neutropenia Treatment Market Size (2014-2019)
5.2 Neutropenia Treatment Key Players in United States
5.3 United States Neutropenia Treatment Market Size by Type
5.4 United States Neutropenia Treatment Market Size by Application
6 Europe
6.1 Europe Neutropenia Treatment Market Size (2014-2019)
6.2 Neutropenia Treatment Key Players in Europe
6.3 Europe Neutropenia Treatment Market Size by Type
6.4 Europe Neutropenia Treatment Market Size by Application
7 China
7.1 China Neutropenia Treatment Market Size (2014-2019)
7.2 Neutropenia Treatment Key Players in China
7.3 China Neutropenia Treatment Market Size by Type
7.4 China Neutropenia Treatment Market Size by Application
8 Japan
8.1 Japan Neutropenia Treatment Market Size (2014-2019)
8.2 Neutropenia Treatment Key Players in Japan
8.3 Japan Neutropenia Treatment Market Size by Type
8.4 Japan Neutropenia Treatment Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Neutropenia Treatment Market Size (2014-2019)
9.2 Neutropenia Treatment Key Players in Southeast Asia
9.3 Southeast Asia Neutropenia Treatment Market Size by Type
9.4 Southeast Asia Neutropenia Treatment Market Size by Application
10 India
10.1 India Neutropenia Treatment Market Size (2014-2019)
10.2 Neutropenia Treatment Key Players in India
10.3 India Neutropenia Treatment Market Size by Type
10.4 India Neutropenia Treatment Market Size by Application
11 Central & South America
11.1 Central & South America Neutropenia Treatment Market Size (2014-2019)
11.2 Neutropenia Treatment Key Players in Central & South America
11.3 Central & South America Neutropenia Treatment Market Size by Type
11.4 Central & South America Neutropenia Treatment Market Size by Application
12 International Players Profiles
12.1 Amgen
12.1.1 Amgen Company Details
12.1.2 Company Description and Business Overview
12.1.3 Neutropenia Treatment Introduction
12.1.4 Amgen Revenue in Neutropenia Treatment Business (2014-2019)
12.1.5 Amgen Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Neutropenia Treatment Introduction
12.2.4 Novartis Revenue in Neutropenia Treatment Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Teva Pharmaceutical
12.3.1 Teva Pharmaceutical Company Details
12.3.2 Company Description and Business Overview
12.3.3 Neutropenia Treatment Introduction
12.3.4 Teva Pharmaceutical Revenue in Neutropenia Treatment Business (2014-2019)
12.3.5 Teva Pharmaceutical Recent Development
12.4 Hospira
12.4.1 Hospira Company Details
12.4.2 Company Description and Business Overview
12.4.3 Neutropenia Treatment Introduction
12.4.4 Hospira Revenue in Neutropenia Treatment Business (2014-2019)
12.4.5 Hospira Recent Development
12.5 Pfizer
12.5.1 Pfizer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Neutropenia Treatment Introduction
12.5.4 Pfizer Revenue in Neutropenia Treatment Business (2014-2019)
12.5.5 Pfizer Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Neutropenia Treatment Key Market Segments
Table Key Players Neutropenia Treatment Covered
Table Global Neutropenia Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Neutropenia Treatment Market Size Market Share by Type 2014-2025
Figure Granulocyte -colony- stimulating factor (G-CSF) Figures
Table Key Players of Granulocyte -colony- stimulating factor (G-CSF)
Figure Antibiotics Figures
Table Key Players of Antibiotics
Figure Antifungal drugs Figures
Table Key Players of Antifungal drugs
Table Global Neutropenia Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacy Case Studies
Figure Retail Pharmacy Case Studies
Figure Online Pharmacy Case Studies
Figure Neutropenia Treatment Report Years Considered
Table Global Neutropenia Treatment Market Size 2014-2025 (Million US$)
Figure Global Neutropenia Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Neutropenia Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Neutropenia Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Neutropenia Treatment Market Share by Regions 2014-2019
Figure Global Neutropenia Treatment Market Share by Regions 2014-2019
Figure Global Neutropenia Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Neutropenia Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Neutropenia Treatment Market Share by Manufacturers (2014-2019)
Figure Global Neutropenia Treatment Market Share by Manufacturers in 2018
Table Global Neutropenia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Neutropenia Treatment Product/Solution/Service
Table Date of Enter into Neutropenia Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Neutropenia Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Neutropenia Treatment Market Size Share by Type (2014-2019)
Figure Global Neutropenia Treatment Market Size Market Share by Type (2014-2019)
Table Global Neutropenia Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Neutropenia Treatment Market Size Share by Application (2014-2019)
Figure Global Neutropenia Treatment Market Size Market Share by Application (2014-2019)
Figure Global Neutropenia Treatment Revenue Market Share by Application in 2018
Figure United States Neutropenia Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Neutropenia Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Neutropenia Treatment Market Share (2018-2019)
Table United States Neutropenia Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Neutropenia Treatment Market Share by Type (2014-2019)
Table United States Neutropenia Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Neutropenia Treatment Market Share by Application (2014-2019)
Figure Europe Neutropenia Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Neutropenia Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Neutropenia Treatment Market Share (2018-2019)
Table Europe Neutropenia Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Neutropenia Treatment Market Share by Type (2014-2019)
Table Europe Neutropenia Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Neutropenia Treatment Market Share by Application (2014-2019)
Figure China Neutropenia Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Neutropenia Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Neutropenia Treatment Market Share (2018-2019)
Table China Neutropenia Treatment Market Size by Type (2014-20189) (Million US$)
Table China Neutropenia Treatment Market Share by Type (2014-2019)
Table China Neutropenia Treatment Market Size by Application (2014-2019) (Million US$)
Table China Neutropenia Treatment Market Share by Application (2014-2019)
Figure Japan Neutropenia Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Neutropenia Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Neutropenia Treatment Market Share (2018-2019)
Table Japan Neutropenia Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Neutropenia Treatment Market Share by Type (2014-2019)
Table Japan Neutropenia Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Neutropenia Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Neutropenia Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Neutropenia Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Neutropenia Treatment Market Share (2018-2019)
Table Southeast Asia Neutropenia Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Neutropenia Treatment Market Share by Type (2014-2019)
Table Southeast Asia Neutropenia Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Neutropenia Treatment Market Share by Application (2014-2019)
Figure India Neutropenia Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Neutropenia Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Neutropenia Treatment Market Share (2018-2019)
Table India Neutropenia Treatment Market Size by Type (2014-2019) (Million US$)
Table India Neutropenia Treatment Market Share by Type (2014-2019)
Table India Neutropenia Treatment Market Size by Application (2014-2019) (Million US$)
Table India Neutropenia Treatment Market Share by Application (2014-2019)
Figure Central & South America Neutropenia Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Neutropenia Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Neutropenia Treatment Market Share (2018-2019)
Table Central & South America Neutropenia Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Neutropenia Treatment Market Share by Type (2014-2019)
Table Central & South America Neutropenia Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Neutropenia Treatment Market Share by Application (2014-2019)
Table Amgen Company Details
Table Amgen Revenue in Neutropenia Treatment Business (2014-2019) (Million US$)
Figure Amgen Revenue Growth Rate in Neutropenia Treatment Business (2014-2019)
Table Amgen Recent Development
Table Novartis Company Details
Table Novartis Revenue in Neutropenia Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Neutropenia Treatment Business (2014-2019)
Table Novartis Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Neutropenia Treatment Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Neutropenia Treatment Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table Hospira Company Details
Table Hospira Revenue in Neutropenia Treatment Business (2014-2019)(Million US$)
Figure Hospira Revenue Growth Rate in Neutropenia Treatment Business (2014-2019)
Table Hospira Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Neutropenia Treatment Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Neutropenia Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Global Neutropenia Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Neutropenia Treatment Market Size Share by Regions (2019-2025)
Figure Global Neutropenia Treatment Market Size Share by Regions in 2025
Figure United States Neutropenia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Neutropenia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Neutropenia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Neutropenia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Neutropenia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Neutropenia Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Neutropenia Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Neutropenia Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Neutropenia Treatment Market Size by Product (2019-2025)
Figure Global Neutropenia Treatment Market Size by Product in 2025
Table Global Neutropenia Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Neutropenia Treatment Market Size by Application (2019-2025)
Figure Global Neutropenia Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
パーキンソン病治療の世界市場：市場規模・現状・予測 Parkinson’s disease (PD) is a chronic and progressive disease, considered an idiopathic form, and accounts for roughly 80% of the cases of Parkinsonism—neurological disorders that lead to movement problems. While the exact cause of Parkinson’s disease is unknown, it may include a number of factors s…- 世界の病院及び薬局ロボティクス市場：専門的調査 The hospital robot is a robot used in the hospital and clinics. They include surgical robots. The global Hospital and Pharmacy Robotics market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Hosp…
- 因子IX欠乏症の治療の世界市場：市場規模・現状・予測 Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B.In this market study, analysts have estimated the prophylaxis segment to dominate the factor IX deficiency treatment market duri…
- 非アルコール性脂肪性肝疾患治療の世界市場：市場規模・現状・予測 Fatty liver disease refers to the accumulation of fat (triglycerides,) in the liver. The liver cell contains fats, but the accumulation of excess fat can be a cause of concern and can lead to liver inflammation known as steatohepatitis. The fatty liver can be caused by alcohol as well as can be non-…
- 第VIII因子欠乏症の治療の世界市場：市場規模・現状・予測 Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is generated in liver sinusoidal cells and endotheli…